Instil Bio, Inc. (TIL) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Instil Bio reported revenue of $9.0M, up 110.2% from $4.3M the year before. Net income was -$71.4M (a -795.9% net margin), or -$10.70 per diluted share. Operating margin was -876.2%. Operating activities generated -$36.6M of cash. At fiscal year end, Instil Bio held $203.5M in total assets against $89.7M in total liabilities, including $6.6M of cash and equivalents.
Open the full interactive Instil Bio financials → Quarterly statements, key ratios, valuation history and price charts.
Instil Bio Key Stats
| Share Price | $6.18 |
|---|---|
| Market Cap | $41.9M |
| Revenue YoY Growth | +110.2% |
| 52-Week Range | $6.18 – $21.10 |
| Shares Outstanding | 6.8 million (basic, 2026 Q2) |
Instil Bio Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $4.3M | $9.0M |
| Operating Income | -$155.6M | -$226.5M | -$159.2M | -$73.5M | -$78.6M |
| Pre-Tax Income | -$156.8M | -$225.2M | -$156.1M | -$74.1M | -$71.4M |
| Income Tax | $39,000 | -$2.1M | $0 | — | $0 |
| Net Income | -$156.8M | -$223.2M | -$156.1M | -$74.1M | -$71.4M |
| Diluted EPS | -$29.60 | -$34.40 | -$24.00 | -$11.39 | -$10.70 |
Instil Bio Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.2M | $2.2M | $2.2M | $2.2M |
| Net Income | -$13.6M | -$8.2M | -$4.2M | -$4.3M |
| Diluted EPS | -$2.01 | -$1.23 | -$0.62 | -$0.63 |
Instil Bio Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $37.6M | $43.7M | $9.2M | $8.8M | $6.6M |
| Current Assets | $464.0M | $269.4M | $160.8M | $124.5M | $191.4M |
| Total Assets | $610.0M | $482.1M | $325.6M | $263.6M | $203.5M |
| Current Liabilities | $41.4M | $32.8M | $10.6M | $7.9M | $4.8M |
| Total Long-Term Debt | — | $72.3M | $81.4M | $84.2M | $84.8M |
| Total Liabilities | $54.8M | $118.5M | $99.8M | $94.1M | $89.7M |
| Shareholders' Equity | $555.2M | $363.6M | $225.8M | $169.4M | $113.9M |
Instil Bio Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$122.1M | -$180.2M | -$82.0M | -$55.7M | -$36.6M |
| Cash From Investing | -$474.4M | $114.5M | $41.1M | $54.0M | $25.5M |
| Cash From Financing | $393.2M | $71.9M | $8.1M | $1.8M | $7.3M |
| Free Cash Flow | -$180.0M | -$264.8M | -$102.7M | -$55.7M | — |
Figures from Instil Bio's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Instil Bio financials page for every line item.
Instil Bio Company Profile
| Ticker | TIL |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Dallas, Texas |
| Incorporated in | New York |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001789769 |
Frequently Asked Questions
What was Instil Bio's revenue in fiscal 2025?
Instil Bio (TIL) reported revenue of $9.0M for fiscal 2025.
What is Instil Bio's annual revenue history?
Instil Bio's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $4.3M; 2025: $9.0M.
What was Instil Bio's net income in fiscal 2025?
Instil Bio reported net income of -$71.4M for fiscal 2025.
What was Instil Bio's earnings per share (EPS) in fiscal 2025?
Instil Bio's diluted EPS was -$10.70 for fiscal 2025 (adjusted for any later stock splits).
What was Instil Bio's revenue last quarter?
In its most recent reported quarter (2026 Q2), Instil Bio reported revenue of $2.2M.
How much debt does Instil Bio have?
Instil Bio reported $84.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Instil Bio are outstanding?
Instil Bio reported a weighted average of 6.8 million basic shares outstanding in 2026 Q2.
What is Instil Bio's market cap?
Based on its latest closing price, Instil Bio (TIL) has a market capitalization of about $41.9M.
When does Instil Bio's fiscal year end?
Instil Bio's fiscal year end, as registered with the SEC, is December 31.
Where is Instil Bio headquartered?
Instil Bio lists its business address in Dallas, Texas in its SEC filings.